# A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

> **NCT00035542** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent

## Interventions

- **DRUG:** Glucovance (metformin HCl/glyburide)
- **DRUG:** metformin HCl
- **DRUG:** glyburide

## Key facts

- **NCT ID:** NCT00035542
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035542, "A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00035542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*